Fund Evaluator:
Invesco S&P SmallCap Health Care ETF (PSCH)
Follow This Fund
Equity
Global Asset Class
Sector Equity
Fund Group
Health
Category
$113.100
NAV (as of Oct 07)
$0.00
Minimum Initial
0.29% A
Expense Ratio
$165 Mil
Assets
Open
Status
na
12b-1 Fee
0.01%
TTM Yield
0.00%
Max Load
42%
Portfolio Turnover
Best Performing in Health Over the Last Year
| 62.8% | Fidelity Advisor Biotechnology Z (FIJYX) |
| 62.6% | Fidelity Advisor Biotechnology I (FBTIX) |
| 56.2% | Eventide Healthcare & Life Sciences N (ETNHX) |
| 53.5% | Fidelity Select Biotechnology (FBIOX) |
| 49.5% | Fidelity Select Pharmaceuticals Port (FPHAX) |
Data as of 7/31/2026
1.9% B
1-Mo Return
19.7% A
3-Mo Return
21.1% A
YTD Return
39.6% C
1-Yr Return
6.4% D
3-Yr Return
-3.3% D
5-Yr Return
1.11 D
Category Risk Index
1.82
Total Risk Index
Fund Details
Fund Family
Invesco
Inception Date
4/7/2010
Share Class Type
Equity Investment Style
Small-Cap
Growth
Bond Investment Style
na
Socially Responsible Fund
No
Index Fund
Yes
Benchmark Index
S&P Composite 1500 TR USD: 100%
Additional Fund Details
Invesco S&P SmallCap Health Care ETF Overview
PSCH Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| PSCH Return (NAV) | 1.9% | 19.7% | 39.6% | 6.4% | -3.3% | 8.0% |
| PSCH Grade | B | A | C | D | D | D |
| +/- Category | 2.3% | 9.0% | 5.8% | -4.3% | -8.3% | -1.3% |
| Health Avg | -0.4% | 10.7% | 33.9% | 10.7% | 5.0% | 9.3% |
| PSCH Tax Cost Ratio | na | na | 0.0% | 0.1% | 0.0% | 0.0% |
PSCH Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| PSCH Return (NAV) | 21.1% | -0.5% | 3.7% | -2.6% | -26.3% | 5.6% | 31.1% | 19.9% | 9.7% | 34.4% | 1.9% |
| PSCH Grade | A | F | B | F | D | C | B | D | A | B | A |
| +/- Category | 14.0% | -21.1% | 1.2% | -8.2% | -16.9% | -3.1% | 6.7% | -8.5% | 9.3% | 11.0% | 12.8% |
| Health Avg | 7.1% | 20.6% | 2.5% | 5.6% | -9.4% | 8.7% | 24.5% | 28.4% | 0.4% | 23.4% | -10.9% |
| Risk Measures | |
| Standard Deviation: | 22.4% |
| Total Risk Index: | 1.82 - High |
| Category Risk Index: | 1.11 - Above Average |
| Category Risk Grade: | D (71% Rank) |
| Beta: | 0.96 |
| R-Squared: | 29% |
| Leveraged Fund: | No |
| Inverse Fund: | No |
| Portfolio Characteristics | |
| Equity Investment Style: | Small-Cap Growth |
| Bond Investment Style: | na |
| Yield: | 0.0% |
| Dividend Distribution: | Quarterly |
| Cap Gains Distribution: | |
| Total Assets: | $165 Mil |
| Fund Total Assets: | $ 165 Mil |
| Share Class Type: | |
| Portfolio Turnover: | 42% |
Management Team
| Number of Managers: 3 | |||
| Longest Tenure: 16.3 years | |||
| Average Tenure: 13.1 years | |||
| Managers (Year): Hubbard Peter (2010), Jeanette Michael (2010), Doshi Pratik (2019) | |||
Portfolio Composition (as of 7/31/26)
| # of Holdings: | 72 |
| % in Top 10 Holdings: | 37.7% |
| Fund is Non-Diversified: | No |
| % in Foreign Issues: | 0.0% |
Portfolio Allocation |
|
| Domestic Stock: | 100.0% |
| Foreign Stock: | 0.0% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 0.0% |
| Cash: | 0.0% |
Purchase Information
| Fund Family: | Invesco |
| Phone Number: | 800-983-0903 |
| Website: | www.invescopowershares.com |
| Status: | Open |
| Inception Date: | April 7, 2010 |
| Min. Initial Purchase: | $ 0 |
| Min. Initial IRA Purchase: | $ 0 |
| True No-Load: | Yes |
| Front Load Maximum: | 0.00% |
| Deferred Charge Maximum: | 0.00% |
| Redemption Charge Maximum: | 0.00% |
| 12b-1 Fee: | na |
Expenses and Fees | |
| Expense Ratio (%): | 0.29% ( Rating : Below Avg ) |
| Category Average Expense Ratio (%): | 1.21% |
| Share Class: | Invesco S&P SmallCap Health Care ETF |
| Min. Subsequent Purchase: | $ 0 |
| Min. Subsequent IRA Purchase: | $ 0 |
Copyright 2026 American Association of Individual Investors and Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.